Exelixis raises $71.8 million through stock offering

South San Francisco-based biotechnology company Exelixis Inc. (EXEL) said it has netted approximately $71.8 million through its public offering of 7 million shares of common stock.

Underwriter Goldman, Sachs & Co. has also been granted a 30-day option to purchase up to an additional 1.05 million shares of common stock.

businessBusiness & Real Estate

If you find our journalism valuable and relevant, please consider joining our Examiner membership program.
Find out more at www.sfexaminer.com/join/
Previous story
Con-way Inc. awards 45 college scholarships
Next story
Rich suburb to save big bucks

Just Posted

Supes approve $13.6B city budget in a 10-1 vote

Supervisor Stefani calls proposal ‘fiscally irresponsible’ in lone ‘nay’ vote

Filipino immersion proposal meets with resistance from school district

Bessie Carmichael parents say current program failing to teach language proficiency

Full lineup of Hardly Strictly Bluegrass announced

20th anniversary roots music festival streams on Oct. 3

Judge will rule later this week on shortening time frame for U.S. census data collection

A federal judge in San Jose heard arguments Tuesday on a preliminary… Continue reading

Breed taps former City Controller Ed Harrington to serve on the public utilities commission

Mayor London Breed has tapped Ed Harrington to sit on the San… Continue reading

Most Read